# active_site_0037

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **B** — Position 139 (Proton donor/acceptor)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MASENNKRKASEEALSPDSQLQSKKARTDSPEREPKSEGGPLGKPPLRIVPFPEKPAVLEERRGEIEFRVVNNDGSRDSFVVLTGLKCIFQKQLPKMPKDYIARLVYDRSHLSIAIVKHPLEVVGGITYRPFNSRRFAEIVFCAISSDQQVKGYGAHLMSHLKDYVKATSPIMHFLTYADNYAIGYFKKQGFTKEITLDKSIWMGYIKDYEGGTIMQCTMLPKIRYLEIGRMLLKQKEAVHAKIRAFSRSHIIHAPPKEWKNGACKIDPLSIPAIKQSGWSPDMDELARQPRHGPNYNQLLHLLNDMQNHSAAWPFTQPVNRDEVPDYYEVIKEPMDLSTMEEKHEKDMYPTPQDFIKDAMLIFDNCRRYNNENTPYAKSANKLEKFMWQQIRNIPEWSVST

[Multiple Choices]
A. Position 331 (Proton acceptor)
B. Position 139 (Proton donor/acceptor)
C. Position 131 (Charge relay)
D. Position 4094 (For beta-ketoacyl synthase 3 activity)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt entry annotates position 139 as an active site proton donor/acceptor, with PubMed experimental evidence; the cited reference includes mutagenesis of Glu-139. This supports choice B, though the primary study was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H2](#evidence-h2), [H3](#evidence-h3), [C10](#evidence-c10).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The 402-residue sequence makes position 4094 impossible, but general sequence inspection does not establish that residue 139 has the specific proton donor/acceptor role rather than the other proposed catalytic roles.


**Missing item-specific fact**

> The experimentally supported, protein-specific assignment of Glu-139 as an active-site proton donor/acceptor.


**Reason**

> Distinguishing the intended answer requires an item-specific catalytic-site annotation or experimental result not supplied with the sequence; recognizing the protein or recalling its database entry would be lookup or memorization.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied reviewer evidence specifically supports B. Position 4094 exceeds the sequence length, and no provided evidence supports the alternative positions or roles.


### Important caveats

- The current and archived database records match the supplied sequence, but the author's exact source snapshot is unknown.
- The experimental support is represented here by a UniProt evidence code and citation; the cited primary paper was not independently examined.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 402-residue sequence makes position 4094 impossible, but general sequence inspection does not establish that residue 139 has the specific proton donor/acceptor role rather than the other proposed catalytic roles.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The experimentally supported, protein-specific assignment of Glu-139 as an active-site proton donor/acceptor.",
    "reason": "Distinguishing the intended answer requires an item-specific catalytic-site annotation or experimental result not supplied with the sequence; recognizing the protein or recalling its database entry would be lookup or memorization."
  },
  "case_id": "active_site_0037",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H2",
      "H3",
      "C10"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry annotates position 139 as an active site proton donor/acceptor, with PubMed experimental evidence; the cited reference includes mutagenesis of Glu-139. This supports choice B, though the primary study was not independently reviewed here."
  },
  "important_caveats": [
    "The current and archived database records match the supplied sequence, but the author's exact source snapshot is unknown.",
    "The experimental support is represented here by a UniProt evidence code and citation; the cited primary paper was not independently examined."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied reviewer evidence specifically supports B. Position 4094 exceeds the sequence length, and no provided evidence supports the alternative positions or roles."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0037",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt entry annotates position 139 as an active site proton donor/acceptor, with PubMed experimental evidence; the cited reference includes mutagenesis of Glu-139. This supports choice B, though the primary study was not independently reviewed here.",
    "evidence_ids": ["C5", "H2", "H3", "C10"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The 402-residue sequence makes position 4094 impossible, but general sequence inspection does not establish that residue 139 has the specific proton donor/acceptor role rather than the other proposed catalytic roles.",
    "missing_item_specific_fact": "The experimentally supported, protein-specific assignment of Glu-139 as an active-site proton donor/acceptor.",
    "reason": "Distinguishing the intended answer requires an item-specific catalytic-site annotation or experimental result not supplied with the sequence; recognizing the protein or recalling its database entry would be lookup or memorization."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied reviewer evidence specifically supports B. Position 4094 exceeds the sequence length, and no provided evidence supports the alternative positions or roles."
  },
  "important_caveats": [
    "The current and archived database records match the supplied sequence, but the author's exact source snapshot is unknown.",
    "The experimental support is represented here by a UniProt evidence code and citation; the cited primary paper was not independently examined."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A7U2QYM2 (Histone acetyltransferase gcnE, Aspergillus flavus) annotates position 139 (Glu/E) as the Active Site with description 'Proton donor/acceptor', supported by experimental evidence (ECO:0000269, PubMed:39601562) including mutagenesis of Glu-139. The sequence confirms position 139 is E (Glutamate), consistent with the catalytic mechanism of GNAT-family histone acetyltransferases. The reference explicitly lists 'ACTIVE SITE' and 'MUTAGENESIS OF GLU-139' among the reported findings.

Citations as saved: [C5](#evidence-c5), [C9](#evidence-c9), [C10](#evidence-c10), [H3](#evidence-h3), [H7](#evidence-h7), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Distractors C (Proline at 131, incompatible with charge relay) and D (position 4094 exceeds the 402-aa sequence length) can be eliminated by basic reasoning. However, distinguishing option A (Asp-331, 'Proton acceptor') from option B (Glu-139, 'Proton donor/acceptor') requires knowing this protein is a GNAT-family HAT and that the catalytic Glu lies adjacent to the acetyl-CoA binding P-loop (residues ~143-185). This proximity information is not provided in the question input.


**Missing item-specific fact**

> The protein's identity as a GNAT-family histone acetyltransferase, the location of its acetyl-CoA binding site, and the specific structural role of Glu-139 versus other acidic residues (e.g., Asp-331) in the catalytic mechanism. Without protein identification or structural context, the sequence alone does not reveal which of multiple acidic residues is the catalytic proton donor/acceptor.


**Reason**

> While two distractors are trivially eliminable (D exceeds sequence length; C is Proline), the core distinction between A (Asp-331) and B (Glu-139) as the catalytic residue requires item-specific knowledge of this protein's family, fold, and active-site geometry. A model must recognize the GNAT HAT signature and recall that the catalytic Glu is positioned near the acetyl-CoA P-loop, which is essentially database/family-level lookup rather than general biological reasoning from the raw sequence.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Option D is impossible (position 4094 > 402 aa). Option C is biologically implausible (Proline cannot form a charge relay). Between A and B, only B is supported by experimental annotation; however, from the raw sequence alone without protein identification, a model could not definitively exclude A. In practice, the question is unambiguous given the correct answer is experimentally validated, but the reasoning path to B requires external knowledge.


### Important caveats

- The UniProt annotation for position 139 is based on experimental evidence (ECO:0000269, PubMed:39601562, 2025 publication) including site-directed mutagenesis, not merely computational transfer.
- The protein was only integrated into Swiss-Prot on 09-Apr-2025; the active-site annotation depends on a very recent publication, limiting the availability of this knowledge to training corpora predating that date.
- The question provides no protein name, EC number, or functional context—only the raw 402-aa sequence—making family recognition and active-site assignment dependent on memorization of sequence-to-function mappings.
- Option D (position 4094, beta-ketoacyl synthase) is an obviously irrelevant distractor referencing a different enzyme class and a position beyond the sequence length.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Distractors C (Proline at 131, incompatible with charge relay) and D (position 4094 exceeds the 402-aa sequence length) can be eliminated by basic reasoning. However, distinguishing option A (Asp-331, 'Proton acceptor') from option B (Glu-139, 'Proton donor/acceptor') requires knowing this protein is a GNAT-family HAT and that the catalytic Glu lies adjacent to the acetyl-CoA binding P-loop (residues ~143-185). This proximity information is not provided in the question input.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's identity as a GNAT-family histone acetyltransferase, the location of its acetyl-CoA binding site, and the specific structural role of Glu-139 versus other acidic residues (e.g., Asp-331) in the catalytic mechanism. Without protein identification or structural context, the sequence alone does not reveal which of multiple acidic residues is the catalytic proton donor/acceptor.",
    "reason": "While two distractors are trivially eliminable (D exceeds sequence length; C is Proline), the core distinction between A (Asp-331) and B (Glu-139) as the catalytic residue requires item-specific knowledge of this protein's family, fold, and active-site geometry. A model must recognize the GNAT HAT signature and recall that the catalytic Glu is positioned near the acetyl-CoA P-loop, which is essentially database/family-level lookup rather than general biological reasoning from the raw sequence."
  },
  "case_id": "active_site_0037",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C9",
      "C10",
      "H3",
      "H7",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A7U2QYM2 (Histone acetyltransferase gcnE, Aspergillus flavus) annotates position 139 (Glu/E) as the Active Site with description 'Proton donor/acceptor', supported by experimental evidence (ECO:0000269, PubMed:39601562) including mutagenesis of Glu-139. The sequence confirms position 139 is E (Glutamate), consistent with the catalytic mechanism of GNAT-family histone acetyltransferases. The reference explicitly lists 'ACTIVE SITE' and 'MUTAGENESIS OF GLU-139' among the reported findings."
  },
  "important_caveats": [
    "The UniProt annotation for position 139 is based on experimental evidence (ECO:0000269, PubMed:39601562, 2025 publication) including site-directed mutagenesis, not merely computational transfer.",
    "The protein was only integrated into Swiss-Prot on 09-Apr-2025; the active-site annotation depends on a very recent publication, limiting the availability of this knowledge to training corpora predating that date.",
    "The question provides no protein name, EC number, or functional context—only the raw 402-aa sequence—making family recognition and active-site assignment dependent on memorization of sequence-to-function mappings.",
    "Option D (position 4094, beta-ketoacyl synthase) is an obviously irrelevant distractor referencing a different enzyme class and a position beyond the sequence length."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Option D is impossible (position 4094 > 402 aa). Option C is biologically implausible (Proline cannot form a charge relay). Between A and B, only B is supported by experimental annotation; however, from the raw sequence alone without protein identification, a model could not definitively exclude A. In practice, the question is unambiguous given the correct answer is experimentally validated, but the reasoning path to B requires external knowledge."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0037",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A7U2QYM2 (Histone acetyltransferase gcnE, Aspergillus flavus) annotates position 139 (Glu/E) as the Active Site with description 'Proton donor/acceptor', supported by experimental evidence (ECO:0000269, PubMed:39601562) including mutagenesis of Glu-139. The sequence confirms position 139 is E (Glutamate), consistent with the catalytic mechanism of GNAT-family histone acetyltransferases. The reference explicitly lists 'ACTIVE SITE' and 'MUTAGENESIS OF GLU-139' among the reported findings.",
    "evidence_ids": ["C5", "C9", "C10", "H3", "H7", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Distractors C (Proline at 131, incompatible with charge relay) and D (position 4094 exceeds the 402-aa sequence length) can be eliminated by basic reasoning. However, distinguishing option A (Asp-331, 'Proton acceptor') from option B (Glu-139, 'Proton donor/acceptor') requires knowing this protein is a GNAT-family HAT and that the catalytic Glu lies adjacent to the acetyl-CoA binding P-loop (residues ~143-185). This proximity information is not provided in the question input.",
    "missing_item_specific_fact": "The protein's identity as a GNAT-family histone acetyltransferase, the location of its acetyl-CoA binding site, and the specific structural role of Glu-139 versus other acidic residues (e.g., Asp-331) in the catalytic mechanism. Without protein identification or structural context, the sequence alone does not reveal which of multiple acidic residues is the catalytic proton donor/acceptor.",
    "reason": "While two distractors are trivially eliminable (D exceeds sequence length; C is Proline), the core distinction between A (Asp-331) and B (Glu-139) as the catalytic residue requires item-specific knowledge of this protein's family, fold, and active-site geometry. A model must recognize the GNAT HAT signature and recall that the catalytic Glu is positioned near the acetyl-CoA P-loop, which is essentially database/family-level lookup rather than general biological reasoning from the raw sequence."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Option D is impossible (position 4094 > 402 aa). Option C is biologically implausible (Proline cannot form a charge relay). Between A and B, only B is supported by experimental annotation; however, from the raw sequence alone without protein identification, a model could not definitively exclude A. In practice, the question is unambiguous given the correct answer is experimentally validated, but the reasoning path to B requires external knowledge."
  },
  "important_caveats": [
    "The UniProt annotation for position 139 is based on experimental evidence (ECO:0000269, PubMed:39601562, 2025 publication) including site-directed mutagenesis, not merely computational transfer.",
    "The protein was only integrated into Swiss-Prot on 09-Apr-2025; the active-site annotation depends on a very recent publication, limiting the availability of this knowledge to training corpora predating that date.",
    "The question provides no protein name, EC number, or functional context—only the raw 402-aa sequence—making family recognition and active-site assignment dependent on memorization of sequence-to-function mappings.",
    "Option D (position 4094, beta-ketoacyl synthase) is an obviously irrelevant distractor referencing a different enzyme class and a position beyond the sequence length."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7U2QYM2` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 21. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7U2QYM2.json)  
**Locator:** `/features/6`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.100326+00:00.  

```json
{"description":"Proton donor/acceptor","evidences":[{"evidenceCode":"ECO:0000269","id":"39601562","source":"PubMed"}],"location":{"end":{"modifier":"EXACT","value":139},"start":{"modifier":"EXACT","value":139}},"type":"Active site"}
```

Source SHA-256: `62832be697e21c858f10966f2857a43e5cbc83ed896c702c9eaf6b22d957a2f7`.

### Evidence C9

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7U2QYM2.json)  
**Locator:** `/features/10`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.100326+00:00.  

```json
{"description":"Important for catalytic activity","evidences":[{"evidenceCode":"ECO:0000250","id":"Q03330","source":"UniProtKB"}],"location":{"end":{"modifier":"EXACT","value":139},"start":{"modifier":"EXACT","value":139}},"type":"Site"}
```

Source SHA-256: `62832be697e21c858f10966f2857a43e5cbc83ed896c702c9eaf6b22d957a2f7`.

### Evidence C10

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7U2QYM2.json)  
**Locator:** `/references/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.100326+00:00.  

```json
{"citation":{"authors":["Chen X.","Wu L.","Zhang Y.","Wang S.","Wang S."],"citationCrossReferences":[{"database":"PubMed","id":"39601562"},{"database":"DOI","id":"10.1128/mbio.02665-24"}],"citationType":"journal article","firstPage":"e0266524","id":"39601562","journal":"MBio","lastPage":"e0266524","publicationDate":"2025","title":"Importance of benzoyltransferase GcnE and lysine benzoylation of alcohol dehydrogenase AdhB in pathogenesis and aflatoxin production in Aspergillus flavus.","volume":"16"},"referenceNumber":2,"referencePositions":["FUNCTION","DISRUPTION PHENOTYPE","CATALYTIC ACTIVITY","DOMAIN","ACTIVE SITE","MUTAGENESIS OF GLU-139"]}
```

Source SHA-256: `62832be697e21c858f10966f2857a43e5cbc83ed896c702c9eaf6b22d957a2f7`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7U2QYM2?format=txt&versions=21)  
**Locator:** `lines 27-35`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 21 / 1.  
**Retrieved:** 2026-11-01T06:27:33.661793+00:00.  

```text
RN   [2]
RP   FUNCTION, DISRUPTION PHENOTYPE, CATALYTIC ACTIVITY, DOMAIN, ACTIVE SITE,
RP   AND MUTAGENESIS OF GLU-139.
RX   PubMed=39601562; DOI=10.1128/mbio.02665-24;
RA   Chen X., Wu L., Zhang Y., Wang S., Wang S.;
RT   "Importance of benzoyltransferase GcnE and lysine benzoylation of alcohol
RT   dehydrogenase AdhB in pathogenesis and aflatoxin production in Aspergillus
RT   flavus.";
RL   MBio 16:e0266524-e0266524(2025).
```

Source SHA-256: `36f550ae7bc08c06f607864032c4242543bb45af90f57f1b6319f8ebe893703c`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7U2QYM2?format=txt&versions=21)  
**Locator:** `lines 141-143`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 21 / 1.  
**Retrieved:** 2026-11-01T06:27:33.661793+00:00.  

```text
FT   ACT_SITE        139
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000269|PubMed:39601562"
```

Source SHA-256: `36f550ae7bc08c06f607864032c4242543bb45af90f57f1b6319f8ebe893703c`.

### Evidence H7

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7U2QYM2?format=txt&versions=21)  
**Locator:** `lines 156-158`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 21 / 1.  
**Retrieved:** 2026-11-01T06:27:33.661793+00:00.  

```text
FT   SITE            139
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q03330"
```

Source SHA-256: `36f550ae7bc08c06f607864032c4242543bb45af90f57f1b6319f8ebe893703c`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 37. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
